310 related articles for article (PubMed ID: 31114479)
21. Identification of UBE3A Protein in CSF and Extracellular Space of the Hippocampus Suggest a Potential Novel Function in Synaptic Plasticity.
Dodge A; Willman J; Willman M; Nenninger AW; Morrill NK; Lamens K; Greene H; Weeber EJ; Nash KR
Autism Res; 2021 Apr; 14(4):645-655. PubMed ID: 33474832
[TBL] [Abstract][Full Text] [Related]
22. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
23. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein.
Cooper EM; Hudson AW; Amos J; Wagstaff J; Howley PM
J Biol Chem; 2004 Sep; 279(39):41208-17. PubMed ID: 15263005
[TBL] [Abstract][Full Text] [Related]
24. From UBE3A to Angelman syndrome: a substrate perspective.
Sell GL; Margolis SS
Front Neurosci; 2015; 9():322. PubMed ID: 26441497
[TBL] [Abstract][Full Text] [Related]
25. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
Tomaić V; Banks L
Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
[TBL] [Abstract][Full Text] [Related]
26. UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease.
Lopez SJ; Segal DJ; LaSalle JM
Front Mol Neurosci; 2018; 11():476. PubMed ID: 30686997
[TBL] [Abstract][Full Text] [Related]
27. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.
Martínez-Noël G; Galligan JT; Sowa ME; Arndt V; Overton TM; Harper JW; Howley PM
Mol Cell Biol; 2012 Aug; 32(15):3095-106. PubMed ID: 22645313
[TBL] [Abstract][Full Text] [Related]
28. Angelman syndrome-associated point mutations in the Zn
Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
[TBL] [Abstract][Full Text] [Related]
29. Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide.
Huang B; Zhou L; Liu R; Wang L; Xue S; Shi Y; Jeong GH; Jeong IH; Li S; Yin J; Cai J
J Med Chem; 2022 Feb; 65(3):2497-2506. PubMed ID: 35045253
[TBL] [Abstract][Full Text] [Related]
30. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
[TBL] [Abstract][Full Text] [Related]
31. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
[TBL] [Abstract][Full Text] [Related]
32. Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.
Pastuzyn ED; Shepherd JD
Front Mol Neurosci; 2017; 10():234. PubMed ID: 28804447
[TBL] [Abstract][Full Text] [Related]
33. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.
Ronchi VP; Klein JM; Edwards DJ; Haas AL
J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172
[TBL] [Abstract][Full Text] [Related]
34. Ube3a/E6AP is involved in a subset of MeCP2 functions.
Kim S; Chahrour M; Ben-Shachar S; Lim J
Biochem Biophys Res Commun; 2013 Jul; 437(1):67-73. PubMed ID: 23791832
[TBL] [Abstract][Full Text] [Related]
35. UBE3A and Its Link With Autism.
Vatsa N; Jana NR
Front Mol Neurosci; 2018; 11():448. PubMed ID: 30568575
[TBL] [Abstract][Full Text] [Related]
36. c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.
Chan AL; Grossman T; Zuckerman V; Campigli Di Giammartino D; Moshel O; Scheffner M; Monahan B; Pilling P; Jiang YH; Haupt S; Schueler-Furman O; Haupt Y
Biochemistry; 2013 May; 52(18):3119-29. PubMed ID: 23581475
[TBL] [Abstract][Full Text] [Related]
37. Towards an understanding of Angelman syndrome in mice studies.
Yang X
J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
[TBL] [Abstract][Full Text] [Related]
38. Catalytically Important Residues of E6AP Ubiquitin Ligase Identified Using Acid-Cleavable Photo-Cross-Linkers.
Krist DT; Statsyuk AV
Biochemistry; 2015 Jul; 54(29):4411-4. PubMed ID: 26161728
[TBL] [Abstract][Full Text] [Related]
39. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
[TBL] [Abstract][Full Text] [Related]
40. Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase
Shi SQ; Mahoney CE; Houdek P; Zhao W; Anderson MP; Zhuo X; Beaudet A; Sumova A; Scammell TE; Johnson CH
Front Behav Neurosci; 2022; 16():837523. PubMed ID: 35401134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
